<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koffel R</submitter><funding>Swiss National Science Foundation</funding><pagination>1688</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6072879</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Bacterial infectious diseases are a leading cause of death. Pore-forming toxins (PFTs) are important virulence factors of Gram-positive pathogens, which disrupt the plasma membrane of host cells and can lead to cell death. Yet, host defense and cell membrane repair mechanisms have been identified: i.e., PFTs can be eliminated from membranes as microvesicles, thus limiting the extent of cell damage. Released into an inflammatory environment, these host-derived PFTs-carrying microvesicles encounter innate immune cells as first-line defenders. This study investigated the impact of microvesicle- or liposome-sequestered PFTs on human macrophage polarization in vitro. We show that microvesicle-sequestered PFTs are phagocytosed by macrophages and induce their polarization into a novel CD14+MHCIIlowCD86low phenotype. Macrophages polarized in this way exhibit an enhanced response to Gram-positive bacterial ligands and a blunted response to Gram-negative ligands. Liposomes, which were recently shown to sequester PFTs and so protect mice from lethal bacterial infections, show the same effect on macrophage polarization in analogy to host-derived microvesicles. This novel type of polarized macrophage exhibits an enhanced response to Gram-positive bacterial ligands. The specific recognition of their cargo might be of advantage in the efficiency of targeted bacterial clearance.</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Host-Derived Microvesicles Carrying Bacterial Pore-Forming Toxins Deliver Signals to Macrophages: A Novel Mechanism of Shaping Immune Responses.</pubmed_title><pmcid>PMC6072879</pmcid><funding_grant_id>159414</funding_grant_id><pubmed_authors>Besancon H</pubmed_authors><pubmed_authors>Drucker P</pubmed_authors><pubmed_authors>Schoenauer R</pubmed_authors><pubmed_authors>Pabst T</pubmed_authors><pubmed_authors>Draeger A</pubmed_authors><pubmed_authors>Larpin Y</pubmed_authors><pubmed_authors>Koffel R</pubmed_authors><pubmed_authors>Mitchell TJ</pubmed_authors><pubmed_authors>Wolfmeier H</pubmed_authors><pubmed_authors>Babiychuk VS</pubmed_authors><pubmed_authors>Babiychuk EB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Host-Derived Microvesicles Carrying Bacterial Pore-Forming Toxins Deliver Signals to Macrophages: A Novel Mechanism of Shaping Immune Responses.</name><description>Bacterial infectious diseases are a leading cause of death. Pore-forming toxins (PFTs) are important virulence factors of Gram-positive pathogens, which disrupt the plasma membrane of host cells and can lead to cell death. Yet, host defense and cell membrane repair mechanisms have been identified: i.e., PFTs can be eliminated from membranes as microvesicles, thus limiting the extent of cell damage. Released into an inflammatory environment, these host-derived PFTs-carrying microvesicles encounter innate immune cells as first-line defenders. This study investigated the impact of microvesicle- or liposome-sequestered PFTs on human macrophage polarization in vitro. We show that microvesicle-sequestered PFTs are phagocytosed by macrophages and induce their polarization into a novel CD14+MHCIIlowCD86low phenotype. Macrophages polarized in this way exhibit an enhanced response to Gram-positive bacterial ligands and a blunted response to Gram-negative ligands. Liposomes, which were recently shown to sequester PFTs and so protect mice from lethal bacterial infections, show the same effect on macrophage polarization in analogy to host-derived microvesicles. This novel type of polarized macrophage exhibits an enhanced response to Gram-positive bacterial ligands. The specific recognition of their cargo might be of advantage in the efficiency of targeted bacterial clearance.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2020-11-20T10:44:41Z</modification><creation>2019-03-26T23:51:15Z</creation></dates><accession>S-EPMC6072879</accession><cross_references><pubmed>30100903</pubmed><doi>10.3389/fimmu.2018.01688</doi></cross_references></HashMap>